Alerts will be sent to your verified email
Verify Email
JFLLIFE
|
JFL Life Sciences
|
Ind-Swift
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.5 % | 13.04 % | 5.42 % |
|
5yr average Equity Multiplier
|
3.23 | -0.95 | 2.09 |
|
5yr Average Asset Turnover Ratio
|
0.95 | 0.57 | 0.96 |
|
5yr Avg Net Profit Margin
|
4.98 % | -31.25 % | 2.86 % |
|
Price to Book
|
0.0 | 0.0 | 4.51 |
|
P/E
|
20.25 | 1.13 | 136.78 |
|
5yr Avg Cash Conversion Cycle
|
217.93 Days | -141.81 Days | 65.55 Days |
|
Inventory Days
|
85.64 Days | 64.0 Days | 25.38 Days |
|
Days Receivable
|
186.74 Days | 88.62 Days | 244.02 Days |
|
Days Payable
|
98.82 Days | 283.86 Days | 179.27 Days |
|
5yr Average Interest Coverage Ratio
|
3.02 | -4.31 | 21.93 |
|
5yr Avg ROCE
|
18.94 % | -53.05 % | 7.69 % |
|
5yr Avg Operating Profit Margin
|
9.53 % | 1.75 % | 4.5 % |
|
5 yr average Debt to Equity
|
1.19 | -1.52 | 0.04 |
|
5yr CAGR Net Profit
|
55.85 % | n/a | -10.11 % |
|
5yr Average Return on Assets
|
4.15 % | -12.25 % | 2.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.47 % | 55.58 % | 46.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
JFL Life Sciences
|
Ind-Swift
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|